Shigeto Ishidoya

Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction

Shigeto Ishidoya, Jeremiah J. Morrissey, Ruth McCracken et al. · Kidney International · 1995 · 327 citations · Full text

Urology, Renal Disease, Renal Function +9

Prospective Randomized Phase II Trial of a Single Early Intravesical Instillation of Pirarubicin (THP) in the Prevention of Bladder Recurrence After Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma: The THP Monotherapy Study Group Trial

Akihiro Ito, Ichiro Shintaku, Makoto Satoh et al. · Journal of Clinical Oncology · 2013 · 241 citations · Full text

Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy

Shigeto Ishidoya, J. J. Morrissey, Ruth McCracken et al. · Kidney International · 1996 · 142 citations

Glomerulonephritis, Urology, Renal Function +10

Immunohistochemistry of a Proliferation Marker Ki67/MIB1 in Adrenocortical Carcinomas: Ki67/MIB1 Labeling Index Is a Predictor for Recurrence of Adrenocortical Carcinomas

Ryo Morimoto, Fumitoshi Satoh, Osamu Murakami et al. · Endocrine Journal · 2008 · 141 citations · Full text

Surgical Oncology, Weiss Score, Pathology +16

Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy.

Jeremiah J. Morrissey, Shigeto Ishidoya, Ruth McCracken et al. · Journal of the American Society of Nephrology · 1996 · 140 citations · Full text

Glomerular Disease, Hypertension, Renal Pathology +23